Harmony Biosciences (HRMY) Holdings announced the appointment of Glenn Reicin as Chief Financial Officer, effective immediately, supporting Harmony’s continued focus on strategic growth, financial strength, and long-term value creation. Most recently, Reicin served as Chief Financial Officer at Eccogene
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HRMY:
- 3 Best ETFs to Invest In, According to AI Analyst, 04/13/2026
- Harmony Biosciences Appoints Peter Anastasiou as Chief Operating Officer
- Harmony Biosciences appoints Anastasiou as Chief Operating Officer
- Harmony Biosciences Eyes Blockbuster Future After Record Year
- Harmony Biosciences price target lowered to $30 from $31 at Deutsche Bank